What is Baxter International Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Baxter International's interest expense for the
three
months ended in Mar. 2024 was $ -103 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-488 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Baxter International's Operating Income for the
three
months ended in Mar. 2024 was $ 219 Mil. Baxter International's Interest Expense for the
three
months ended in Mar. 2024 was $ -103 Mil.
Baxter International's Interest Coverage for the quarter that ended in Mar. 2024 was 2.13.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Baxter International Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-488 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (NYSE:BAX) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Baxter International's Interest Expense for the
three
months ended in Mar. 2024 was $-103 Mil. Its
Operating Income
for the
three
months ended in Mar. 2024 was $219 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2024 was $11,536 Mil.
Baxter International's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Baxter International (Baxter International) Business Description
Traded in Other Exchanges
Address
One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
Executives
| Joel T. Grade |
officer: EVP, Chief Financial Officer |
SYSCO CORPORATION, 1390 ENCLAVE PARKWAY, HOUSTON TX 77077 |
| Stephen H Rusckowski |
director |
C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
| Ampofo William A. Ii |
director |
ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Christopher A. Toth |
officer: EVP, Group Pres, Kidney Care |
1252 COOLIDGE AVE., SAN JOSE CA 95125 |
| Stroucken Albert P L |
director |
BAXTER INTERNATIONAL INC., ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Reaz Rasul |
officer: EVP, Group Pres, Healthcare |
ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Alok Sonig |
officer: EVP, Group President, Pharm |
ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Heather Knight |
officer: EVP, Group Pres, Medical |
ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Jacqueline Kunzler |
officer: SVP, Chief Quality Officer |
ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Jeanne K Mason |
officer: CVP, Human Resources |
ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Steven Flynn |
officer: SVP, President, APAC |
ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
| Peter M Wilver |
director |
|
| David Brent Shafer |
director |
2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117 |
| Amy Mcbride Wendell |
director |
COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048 |
| Cathy R Smith |
director |
TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403 |
Baxter International (Baxter International) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BAX has been successfully added to your 